acrylamide
4,99 €
Chemical reagent Akrylamid (CAS 79-06-1). Full encyclopedic card — classification, properties and safety data — below.
🔒 SALE BLOCKED BY THE SYSTEM
Akryloamid · restriction (REACH Annex XVII)
Annex XVII · Art. 67(1) · REACH Regulation (EC) No 1907/2006
Block applied automatically from the regulatory canon, not by an operator decision. Legal Basis ↗
Chemical Overview: AcrylamideMolGod_OVERVIEW_1
| Molecular formula | C3H5NO |
| Molecular weight | 71.08 g/mol |
| Melting point | 84.5 °C |
| Density | 1.13 g/cm³ |
| LogP (lipophilicity) | -0.7 |
| IUPAC name | prop-2-enamide |
| SMILES | C=CC(=O)N |
| InChIKey | HRPVXLWXLXDGHG-UHFFFAOYSA-N |
Synonyms: ACRYLAMIDE · 79-06-1 · 2-Propenamide · prop-2-enamide · Propenamide
Data sources: PubChem (NLM/NIH)
Last updated: 2026-11-10
SCIENTIFIC RESEARCH
📚 Scientific references (Chicago Author-Date) 11 refs · 3 baz
MOLEKUŁA Per-CAS bibliography (live from 13+ databases)
Sources: db:openalex (8) · db:core (3)
- db:openalex Jong‐Su Park, Palas Samanta, Sangwoo Lee et al.. (2021). "Developmental and Neurotoxicity of Acrylamide to Zebrafish". International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22073518 →
- db:openalex Melissa Faria, Tamar Ziv, Cristian Gómez‐Canela et al.. (2018). "Acrylamide acute neurotoxicity in adult zebrafish". Scientific Reports. https://doi.org/10.1038/s41598-018-26343-2 →
- db:openalex N. Muttucumaru, Stephen J. Powers, J. Stephen Elmore et al.. (2016). "Acrylamide-forming potential of potatoes grown at different locations, and the ratio of free asparagine to reducing sugars at which free asparagine becomes a limiting factor for acrylamide formation". Food Chemistry. https://doi.org/10.1016/j.foodchem.2016.09.199 →
- db:openalex (2012). "Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water studies).". PubMed.
- db:openalex Claudio Pelucchi, Carlo La Vecchia, Cristina Bosetti et al.. (2011). "Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies". Annals of Oncology. https://doi.org/10.1093/annonc/mdq610 →
- db:openalex European Food Safety Authority. (2011). "Results on acrylamide levels in food from monitoring years 2007–2009 and Exposure assessment". EFSA Journal. https://doi.org/10.2903/j.efsa.2011.2133 →
- db:openalex Burhan I. Ghanayem, Re Bai, Grace E. Kissling et al.. (2009). "Diet-Induced Obesity in Male Mice Is Associated with Reduced Fertility and Potentiation of Acrylamide-Induced Reproductive Toxicity1". Biology of Reproduction. https://doi.org/10.1095/biolreprod.109.078915 →
- db:openalex Sean M. Hays, Lesa L. Aylward. (2008). "Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)". Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2008.05.010 →
- db:core Skott, A., Hofmann, A., Sorgel, F. et al.. (2002). "Acrylamide: Increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans". https://doi.org/10.1159/000069715 →
- db:core Lawrence, Justin R., O\u27Neill, Feidhlim T., O'Neill, Feidhlim T. et al.. (2001). "Thickness variation of self-processing acrylamide-based photopolymer and reflection holography". https://doi.org/10.1117/1.1353801 →
- db:core (0). "NIOSH skin notation profile : acrylamide [CAS No. 79-06-1]".
Physicochemical properties
Quick Reference
Detailed Properties
| Property | Value | Unit | Conditions | Source |
|---|---|---|---|---|
| Density (ρ) | 1.1300 | g/cm³ | 20 °C (68 °F) | |
| Melting Point (mp) | 84.50 °C (184.1 °F) | 1 atm | ||
| Flash Point | 137.80 °C (280 °F) | closed cup | ||
| Water Solubility | soluble (≥999) | g/L | 25 °C (77 °F) |
🔬 Advanced Properties
Chemical Identifiers
C=CC(=O)N Data sources: PubChem, NIST Chemistry WebBook, CRC Handbook of Chemistry and Physics (103rd ed.)
Last updated: 2026-06-30
📡 Spectroscopy — CAS 79-06-1MolGod_SPECHUB_MAIN
Spectroscopic spectra databases — inline data 9 sources MolGod_SPECDB_2
Spectra are fetched on demand from 9 sources. Each spectrum is stored in our database — the next time it is opened there are zero requests to the external API. Download JCAMP-DX / CSV / PNG for every spectrum without searching.
Reference source — no public API. Open in an external database:
🔗 IR/NMR/MS (SDBS) →Reference source — no public API. Open in an external database:
🔗 JP Monograph →Reference source — no public API. Open in an external database:
🔗 WHO INN →Reference source — no public API. Open in an external database:
🔗 DOAJ →Physical & Chemical Properties (DB) 6 fields MolGod Score: No source
| Property | Value | Unit | Conditions | Source |
|---|---|---|---|---|
| Melting point | 84.50 | °C | 1 atm | |
| Water solubility | soluble (≥999) | g/L | 25°C | |
| Density (ρ) | 1.1300 | g/cm³ | 20°C | |
| Flash point | 137.80 | °C | closed cup | |
| Autoignition temperature | 240.00 | °C | in air | |
| logP (octanol/water) | -0.700 | — | 25°C |
📚 Scientific references (Chicago Author-Date) (12 sources)
- Haynes, William M., ed. 2024. CRC Handbook of Chemistry and Physics. 105th ed. Boca Raton: CRC Press/Taylor & Francis. ISBN 978-1-032-55554-4. ↗
- National Institute of Standards and Technology. 2024. "NIST Chemistry WebBook, SRD 69." Gaithersburg, MD: NIST. Accessed 2025-01-01. ↗
- Yaws, Carl L. 2014. The Yaws Handbook of Physical Properties for Hydrocarbons and Chemicals. 2nd ed. Oxford: Gulf Professional Publishing.
- PubChem. 2024. "PubChem Compound Database." National Library of Medicine, National Institutes of Health. Accessed 2025-01-01. ↗
- Marrero, J., and R. Gani. 2001. "Group-Contribution Based Estimation of Pure Component Properties." Fluid Phase Equilibria 183–184: 183–208. ↗
- Joback, K. G., and R. C. Reid. 1987. "Estimation of Pure-Component Properties from Group-Contributions." Chemical Engineering Communications 57 (1–6): 233–243. ↗
- Sangster, J. 1997. Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry. Chichester: Wiley. ISBN 978-0-471-97397-3.
- Mannhold, Raimund, and Han van de Waterbeemd. 2001. "Substructure and Whole Molecule Approaches for Calculating Log P." Journal of Computer-Aided Molecular Design 15 (4): 337–354. ↗
- Perrin, Ditlev D., Boyd Dempsey, and E. P. Serjeant. 1981. pKa Prediction for Organic Acids and Bases. London: Chapman and Hall. ISBN 0-412-21090-5.
- Constantinou, Leonidas, and Rafiqul Gani. 1994. "New Group Contribution Method for Estimating Properties of Pure Compounds." AIChE Journal 40 (10): 1697–1710. ↗
- Ertl, Peter, Bernhard Rohde, and Paul Selzer. 2000. "Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties." Journal of Medicinal Chemistry 43 (20): 3714–3717. ↗
🛡️ Safety — CAS 79-06-1MolGod_SAFEHUB_MAIN
GHS/CLP classification — Regulation (EC) No 1272/2008 + UN GHS Rev. 9 (2021).
🚨 Hazard statements (H)
- H350 — May cause cancer
- H340 — May cause genetic defects
- H361f — Suspected of damaging fertility
- H332 — Harmful if inhaled
- H312 — Harmful in contact with skin
- H301 — Toxic if swallowed
- H372 — Causes damage to organs through prolonged or repeated exposure
- H315 — Causes skin irritation
- H319 — Causes serious eye irritation
- H317 — May cause an allergic skin reaction
🛡 Precautionary statements (P)
- P203 — Obtain, read and follow all safety instructions before use
✓ Harmonised classification pursuant to Annex VI of the CLP Regulation (EC) 1272/2008 (official, binding classification). Index number: 616-003-00-0.
Reference (Chicago): European Chemicals Agency. "acrylamide; prop-2-enamide, Index No. 616-003-00-0." In Table 3 of Annex VI to Regulation (EC) No 1272/2008 (CLP Regulation), 23rd Adaptation to Technical Progress. Helsinki: European Chemicals Agency, 2026. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp.
Translations: CLP Regulation (EC) 1272/2008, Annexes III and IV. Data: PubChem/NLM.
📚 Consolidated scientific references — Chicago Author-Date 10 sources
References collected from all Safety Hub tabs. CAS: 79-06-1 ·
PubChem ↗
- Parlament Europejski i Rada UE. 2008. "Rozporządzenie (WE) nr 1272/2008 w sprawie klasyfikacji, oznakowania i pakowania substancji (CLP)." Dz.Urz. UE L 353. [↗] GHS, Regulations
- United Nations Economic Commission for Europe (UNECE). 2021. "Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Ninth Revised Edition." United Nations, Geneva. [↗] GHS
- Goldfrank, Lewis R., Robert S. Hoffman, Mary Ann Howland, et al.. 2019. "Goldfrank's Toxicologic Emergencies, 11th ed.." McGraw-Hill Education, New York. ISBN 978-1-25-985961-8. Pierwsza pomoc, Toksykologia
- National Institute for Occupational Safety and Health (NIOSH). 2023. "NIOSH Pocket Guide to Chemical Hazards (DHHS Publ. 2005-149)." U.S. Department of Health and Human Services / CDC, Cincinnati, OH. [↗] Pierwsza pomoc, PPE, Toksykologia
- European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms." CEN, Brussels. [↗] PPE
- UNECE. 2023. "European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." United Nations, Geneva. [↗] Utylizacja, Regulacje
- National Fire Protection Association (NFPA). 2022. "NFPA 400 — Hazardous Materials Code." NFPA, Quincy, MA. [↗] Magazynowanie
- Urben, P.G. (ed.). 2017. "Bretherick's Handbook of Reactive Chemical Hazards, 8th ed.." Butterworth-Heinemann / Elsevier, Oxford. [↗] Magazynowanie
- Ministerstwo Klimatu i Środowiska RP. 2023. "Baza danych o produktach i opakowaniach oraz o gospodarce odpadami (BDO)." Ministerstwo Klimatu i Środowiska, Warszawa. [↗] Utylizacja
- International Agency for Research on Cancer (IARC / WHO). 2024. "IARC Monographs on the Identification of Carcinogenic Hazards to Humans — List of Classifications." WHO, Lyon. [↗] Toksykologia
Tabs with their own references (Emergency, PPE, Storage, Waste) contain additional bibliographic entries within their respective sections.
Analytical statistics (t-test · RSD · Grubbs · Q-Dixon) ICH Q2
Paste a series of replicate measurements (CSV, or one number per line). The calculator computes the mean, standard deviation and 95% CI, and detects outliers (Grubbs + Dixon Q).
📐 Statistical formulas
x̄ = Σxᵢ / n— arithmetic means² = Σ(xᵢ - x̄)² / (n-1)— sample variances = √s²— standard deviationRSD% = (s / x̄) × 100%— relative standard deviationCI₉₅ = x̄ ± t(0.05, n-1) × s / √n— Student's tG = |xᵢ - x̄| / s— Grubbs' testQ = |xsuspect - xnearest| / |xmax - xmin|— Dixon Q-test
Source: ICH Q2(R2) Validation of Analytical Procedures · ICH PDF ↗
Buffer Recipe Calculator UNIQUE
Choose a buffer from the list of 20 popular systems → enter the target pH → get an exact recipe with the masses to weigh out.
Step 1: Choose a buffer system
📜 Recipe history (last 10)
🔧 HPLC troubleshooting — decision tree 6 common problems
Diagnostics for the 12 most common HPLC problems with a decision tree (5 steps per problem). Source: Snyder/Kirkland/Dolan 3rd ed. Chapter 17 + LCGC LC Troubleshooting columns 1989-2024.
Broad peaks medium
Symptom: All peaks on the chromatogram are wider than expected (FWHM > 2× normal)
🔍 Diagnostic tree:
-
1. Check whether all peaks are broadened or only some
→ YES: All → instrumental problem (column or system)
→ NO: Only some → chemistry problem (interaction with the column for specific analytes) -
2. Swap in a test column — does the problem disappear?
→ YES: COLUMN worn out — packing damaged, void in the first few mm. Replace it.
→ NO: Problem in the LC system -
3. Check the dead volume — injection loop, connections, detector
→ YES: Loop > 100 µL for a 4.6 mm column or loose connections → replace ferrules, shorten tubing
→ NO: Continue diagnostics -
4. Temperature test: raise the column from 25°C to 40°C
→ YES: Narrower peaks → mass-transfer kinetics too slow (increase T)
→ NO: Continue -
5. Check flow rate vs the optimal van Deemter value for this column
→ YES: Optimum for 4.6mm/5µm = 1.0 mL/min, for 2.1mm/3µm = 0.4 mL/min
→ NO: Continue
- Column worn out (>2000 injections without a guard)
- System dead volume > 100 µL (wrong loop, long tubing, loose ferrules)
- Temperature too low (mass-transfer kinetics)
- Flow rate outside the van Deemter optimum
- Sample solvent stronger than mobile phase A
- ✓ Replace the column (when >2000 injections)
- ✓ Check all connections — keep tubing as short as possible
- ✓ Increase column T to 40°C (if the substance is stable)
- ✓ Reduce flow to the van Deemter optimum
- ✓ Dissolve the sample in mobile phase A (not in pure organic)
Peak tailing (T > 1.5) high
Symptom: Peaks have an extended "tail" on the late-elution side (asymmetry T = b/a > 1.5 per USP)
🔍 Diagnostic tree:
-
1. Does the substance contain basic groups (amino, pyridine)?
→ YES: Yes → silanol interactions! Add 0.1% TFA or 5-10 mM TEA to mobile phase A.
→ NO: Continue -
2. Check the mobile-phase pH vs the substance pKa
→ YES: pH = pKa ± 1 → partial ionization, peak split. Move pH ≥ 2 units away from pKa.
→ NO: Continue -
3. Check the column age (>1500 injections?)
→ YES: Yes → exposed silanols (column bleed). Replace with a column with higher endcapping (XTerra, Symmetry).
→ NO: Continue -
4. Does the sample contain metals (Fe, Cu from glass vials)?
→ YES: Yes → use type II clear vials or PFA. Add 0.1mM EDTA to the sample.
→ NO: Continue
- Silanol interactions (basic analyte + silica gel free silanols)
- pH at the boundary of the analyte pKa (peak split)
- Old column (column bleed, high silanol activity)
- Metals in the sample (chelation → tailing)
- Column overload (>50 µg on a 4.6mm column)
- ✓ Add 0.1% TFA (UV) or 0.1% formic acid (LC-MS) to mobile phase A
- ✓ Choose a column with high-purity endcapping: Waters XBridge BEH, Phenomenex Kinetex
- ✓ Work at pH ≥ 2 units away from pKa
- ✓ Add 0.1mM EDTA to the sample (Fe/Cu chelation)
- ✓ Reduce the injection volume to ≤ 20 µL for a 4.6mm column
Baseline drift medium
Symptom: The baseline rises or falls systematically for >5 minutes
🔍 Diagnostic tree:
-
1. Are you running a gradient (B% increasing)?
→ YES: Yes → different absorption of phases A vs B at dλ. Solvent change in UV cutoff. Check the % organic UV absorbance.
→ NO: Continue (isocratic) -
2. Check the column temperature — is it stable to ±0.5°C?
→ YES: Yes (stable) → continue
→ NO: Unstable → turn on the column thermostat (>25°C controlled) -
3. Test: turn off the autosampler, run pump+column+detector alone
→ YES: Drift disappears → autosampler contamination (clean the needle, septum)
→ NO: Continue -
4. Check the lamp age (D2 for UV)
→ YES: Yes (>1500 hours) → replace the lamp
→ NO: Continue
- Gradient elution with different UV cutoff of the phases
- Unstable column T
- Autosampler contamination of the needle/septum
- Old UV lamp (>1500h)
- Detector flow cell fouled
- Column not equilibrated (<10 column volumes)
- ✓ Pre-equilibrate the column for 10-15 column volumes at 100% A
- ✓ Column thermostat on, T 30-40°C stable
- ✓ Clean the detector flow cell with 50:50 ACN:H2O
- ✓ Replace the D2 lamp if >1500h
- ✓ Use baseline subtraction (Chromeleon, Empower native function)
No peak / lost peak critical
Symptom: The expected analyte peak does not appear on the chromatogram
🔍 Diagnostic tree:
-
1. Did the injection actually take place?
→ YES: Check the autosampler log, pump pressure (should drop during injection)
→ NO: Autosampler problem → check the loop, needle, sample in the vial -
2. Is the sample in the vial (correct volume, not evaporated)?
→ YES: Continue
→ NO: No sample — re-pipette -
3. Sample stability — prepared >24h ago?
→ YES: Yes → degradation. Re-prepare a fresh sample.
→ NO: Continue -
4. Check the detection wavelength vs the substance λmax
→ YES: Detection at λ does NOT match λmax → no signal. Scan DAD 200-400nm.
→ NO: Continue -
5. Test: inject a pure standard (of known concentration, fresh)
→ YES: The standard gives a peak → problem with the sample (matrix, derivatization)
→ NO: No peak even with the standard → system problem (column, phase, gradient)
- Sample not drawn from the vial (autosampler bug)
- Sample degraded (>24h pH/temp/light)
- Detection at the wrong wavelength
- Wrong mobile phase (e.g. forgotten TFA)
- Column reversed / wrong stationary phase
- Substance elutes at the front (V0) → unretained, not visible
- ✓ Re-prepare a fresh sample per the exact protocol
- ✓ UV-Vis DAD scan 200-400nm + search for λmax
- ✓ Check the mobile-phase composition — was TFA added?
- ✓ Test the reverse column direction (carefully!)
- ✓ For retention <1 min — lower the % B, MeOH instead of ACN
- ✓ Check the "expected_rt" table in wp_molgod_hplc_methods
Pressure too high critical
Symptom: Pump pressure > 80% of the column max or system shutdown with a high-pressure error
🔍 Diagnostic tree:
-
1. Check that the column is connected correctly (arrow direction)
→ YES: OK
→ NO: Column reversed → flip it (never run it "backwards") -
2. Test: remove the column from the system, run pump+detector alone
→ YES: Pressure drops to <50 bar → problem in the column (clogged)
→ NO: Pressure stays high → in-line filter clogged, frit fouled -
3. Check the pre-column filter (in-line frit)
→ YES: Fouled and brown → replace it
→ NO: Continue -
4. Back-flush the column with 50:50 ACN:H2O without the column — does it disappear?
→ YES: Particles stuck in the first mm — a 30 min flush may recover it
→ NO: Replace the column
- In-line filter (frit) clogged with particles
- Buffer salting out (precipitation at high %B)
- Sample contains suspended matter (filter 0.22 µm before injection)
- Column clogged (column bed compaction)
- Gradient with a buffer phase + high organic → salt precipitation
- ✓ ALWAYS filter the sample through 0.22 µm PVDF before injection
- ✓ Replace the in-line filter every 100 injections (or when pressure rises >20%)
- ✓ Do NOT use >20mM phosphate buffer + >70% ACN (the salt precipitates)
- ✓ Flush the column for 30 min with 50:50 ACN:H2O in the reverse direction (when the manufacturer allows it)
- ✓ Pre-column 4×3mm to protect the main column
Ghost peaks high
Symptom: Unexplained peaks on the chromatogram absent from the calibration
🔍 Diagnostic tree:
-
1. Test: blank injection (pure sample solvent)
→ YES: A ghost appears → contamination of the system or eluents
→ NO: Appears only with the sample → matrix -
2. Does the ghost grow with the gradient (elutes at high %B)?
→ YES: Yes → overloaded column or strong-retained from a previous run
→ NO: Independent of the gradient → autosampler carryover -
3. Increase carryover wash (between injections)
→ YES: Helps → carryover was to blame. Use a stronger wash protocol.
→ NO: Continue -
4. Pure water injection — is there a peak?
→ YES: Yes → contamination of the water source (organics from the DI system)
→ NO: Continue
- Carryover in the autosampler needle/loop
- Eluent contamination (even HPLC-grade)
- Strong-retained components from previous runs
- Plastic in the vials (phthalates, PEG from the caps)
- Insufficiently purified DI water
- ✓ Strengthen the wash protocol: 100% B → 100% A → 50:50 (3 cycles)
- ✓ Strong wash: 100% DMSO or 100% MeOH before calibration
- ✓ Filter the eluents through 0.22 µm PTFE if in doubt
- ✓ Use amber glass + Teflon-lined caps for samples
- ✓ Periodic gradient ramp to 100% B for 10 min (clean-out)
📚 Scientific references (Chicago Author-Date) — click to expand
- Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. Introduction to Modern Liquid Chromatography. 3rd ed. John Wiley & Sons. Chapter 17 (Troubleshooting) pp. 559-616. ISBN 978-0-470-16754-0. https://doi.org/10.1002/9780470508183 [link ↗]
- Dolan, John W.. 2014. LC Troubleshooting (monthly column 1989-2024). LCGC North America. [link ↗] — John Dolan 35-letnia seria miesięcznych artykułów problemowych
- Kromidas, Stavros. 2017. HPLC Made to Measure: A Practical Handbook for Optimization. 2nd ed. Wiley-VCH. ISBN 978-3-527-31377-1. — Praktyczny przewodnik problem-solving dla labs analitycznych
- Dolan, John W.. 2013. When to Modify Method Conditions. 192-199. [link ↗] — Decision flow for changing flow rate / temperature / %B vs swapping columns.
- Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. 2nd ed. Wiley. ISBN 978-1-119-31378-3. https://doi.org/10.1002/9781119313793 [link ↗] — Chapter 9 covers troubleshooting modern UHPLC systems (sub-2 µm particles).
- Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. 5th ed. Wiley. ISBN 978-0-470-68218-0. — Solid step-by-step problem isolation chapter (eluents, columns, instruments).
- Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. Practical HPLC Method Development. 2nd ed. Wiley. ISBN 978-0-471-00703-6. — Method-development companion volume with troubleshooting cross-refs.
- Carr, Peter W.. 2009. The new physical chemistry of HPLC. 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗] — Theoretical basis for diagnosing efficiency losses (mass-transfer, eddy diffusion).
- Heyden, Yvan Vander, et al.. 2009. Robustness of pharmaceutical liquid chromatographic methods. 2120-2129. https://doi.org/10.1016/j.jchromb.2008.10.052 [link ↗] — How to diagnose method failures vs. system failures (Plackett-Burman).
- Engelhardt, Heinz. 2014. 100 Years of Chromatography. 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5. — Historical context for ghost-peak phenomenology (silica chemistry).
- Stoll, Dwight R., and Peter W. Carr. 2017. Two-Dimensional Liquid Chromatography: A State of the Art Tutorial. 519-531. https://doi.org/10.1021/acs.analchem.6b03506 [link ↗]
- Carr, Peter W.. 2009. The new physical chemistry of HPLC. 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094 [link ↗]
- Wu, Naijun, and Anton M. Clausen. 2007. Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations. 1167-1182. https://doi.org/10.1002/jssc.200700026 [link ↗]
- Engelhardt, Heinz. 2014. 100 Years of Chromatography. 2nd ed. Wiley-VCH. ISBN 978-3-527-33473-5.
- Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. Probabilistic approach to peak deconvolution in chromatography. 8525-8531. https://doi.org/10.1021/ac101742z [link ↗]
ADMET — Pharmacological Profile
Drug-likeness radar chart (Lipinski Ro5 / Veber). Green zone = compliance with criteria.
Predictive data — properties calculated in silico (SMILES/RDKit). These do not replace clinical studies. Do not use for drug evaluation without experimental verification.
| Property | Value | Rating |
|---|---|---|
| Absorption (GI) | high | ✓ |
| BBB permeability | yes (crosses) | |
| Bioavailability (Daina 2017) | 55% | |
| CYP450 profile | CYP1A2 non-inhibitorCYP2C9 non-inhibitorCYP2C19 non-inhibitorCYP2D6 non-inhibitorCYP3A4 non-inhibitor | |
| PAINS alerts | 1 | ⚠ |
| Brenk alerts | 1 | ⚠ |
| pKa (pH 7.4) | 9 (predicted) | |
| hERG (cardiotox.) | ✓ no | |
| P-gp substrate | — | |
| Ames mutagenicity | ✓ no | |
| DILI (hepatotox.) | — | |
| LogS (aq. solub.) | — | |
Sources (ADMET methodology)
- Lipinski, Christopher A., Franco Lombardo, Beryl W. Dominy, and Paul J. Feeney. 1997. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings." Advanced Drug Delivery Reviews 23 (1-3): 3-25.
- Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, et al. 2002. "Molecular properties that influence the oral bioavailability of drug candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
- Daina, Antoine, Olivier Michielin, and Vincent Zoete. 2017. "SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness." Scientific Reports 7: 42717.
- Egan, William J., and Gregory Lauri. 2002. "Prediction of intestinal permeability." Advanced Drug Delivery Reviews 54 (3): 273-289.
- Baell, Jonathan B., and Georgina A. Holloway. 2010. "New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries." Journal of Medicinal Chemistry 53 (7): 2719-2740.
- Brenk, Ruth, Alessandro Schipani, Daniel James, et al. 2008. "Lessons learnt from assembling screening libraries for drug discovery for neglected diseases." ChemMedChem 3 (3): 435-444.
- Ertl, Peter, and Ansgar Schuffenhauer. 2009. "Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions." Journal of Cheminformatics 1: 8.
- Bickerton, G. Richard, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and Andrew L. Hopkins. 2012. "Quantifying the Chemical Beauty of Drugs." Nature Chemistry 4 (2): 90-98.
- Hopkins, Andrew L., and Colin R. Groom. 2002. "The Druggable Genome." Nature Reviews Drug Discovery 1 (9): 727-730.
- Ghose, Arup K., Vellarkad N. Viswanadhan, and John J. Wendoloski. 1999. "A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery." Journal of Combinatorial Chemistry 1 (1): 55-68.
- Tice, Raymond R., Christopher P. Austin, Robert J. Kavlock, and John R. Bucher. 2013. "Improving the Human Hazard Characterization of Chemicals: A Tox21 Update." Environmental Health Perspectives 121 (7): 756-765.
- Leeson, Paul D., and Brian Springthorpe. 2007. "The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry." Nature Reviews Drug Discovery 6 (11): 881-890.
- Hann, Michael M. 2011. "Molecular Obesity, Potency and Other Addictions in Drug Discovery." MedChemComm 2 (5): 349-355.
- Davies, Mark, Michał Nowotka, George Papadatos, et al. 2015. "ChEMBL Web Services: Streamlining Access to Drug Discovery Data and Utilities." Nucleic Acids Research 43 (W1): W612-W620.
- Walters, W. Patrick, and Mark A. Murcko. 2002. "Prediction of 'Drug-Likeness.'". Advanced Drug Delivery Reviews 54 (3): 255–271. https://doi.org/10.1016/S0169-409X(02)00003-0.
- Congreve, Miles, Robin Carr, Christopher Murray, and Harren Jhoti. 2003. "A 'Rule of Three' for Fragment-Based Lead Discovery?" Drug Discovery Today 8 (19): 876–877. https://doi.org/10.1016/S1359-6446(03)02831-9.
- Brenk, Ruth, Alessandro Schipani, Daniel James, Agata Krasowski, Iain Hugh Gilbert, Julie Frearson, and Paul Graham Wyatt. 2008. "Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases." ChemMedChem 3 (3): 435-444.
- Schomburg, Karen T., Sascha Bietz, Hans Briem, Andrea M. Henzler, Stefan Urbaczek, and Matthias Rarey. 2014. "Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening." Journal of Chemical Information and Modeling 54 (6): 1676-1686.
- Bemis, Guy W., and Mark A. Murcko. 1996. "The Properties of Known Drugs. 1. Molecular Frameworks." Journal of Medicinal Chemistry 39 (15): 2887-2893.
- Schomburg, Karen T., and Matthias Rarey. 2014. "What Is the Potential of Structure-Based Target Prediction Methods?" Future Medicinal Chemistry 6 (17): 1987-1989.
- Jackson, Paul A., John C. Widen, Daniel A. Harki, and Kay M. Brummond. 2017. "Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions." Journal of Medicinal Chemistry 60 (3): 839-885. ↗
- Jackson, Paul A., et al. 2017. "Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions." Journal of Medicinal Chemistry 60 (3): 839-885. ↗
- Jong‐Su Park, Palas Samanta, Sangwoo Lee et al.. (2021). "Developmental and Neurotoxicity of Acrylamide to Zebrafish". International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22073518
- Melissa Faria, Tamar Ziv, Cristian Gómez‐Canela et al.. (2018). "Acrylamide acute neurotoxicity in adult zebrafish". Scientific Reports. https://doi.org/10.1038/s41598-018-26343-2
- N. Muttucumaru, Stephen J. Powers, J. Stephen Elmore et al.. (2016). "Acrylamide-forming potential of potatoes grown at different locations, and the ratio of free asparagine to reducing sugars at which free asparagine becomes a limiting factor for acrylamide formation". Food Chemistry. https://doi.org/10.1016/j.foodchem.2016.09.199
- (2012). "Toxicology and carcinogenesis studies of acrylamide (CASRN 79-06-1) in F344/N rats and B6C3F1 mice (feed and drinking water studies).". PubMed.
- Claudio Pelucchi, Carlo La Vecchia, Cristina Bosetti et al.. (2011). "Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies". Annals of Oncology. https://doi.org/10.1093/annonc/mdq610
- European Food Safety Authority. (2011). "Results on acrylamide levels in food from monitoring years 2007–2009 and Exposure assessment". EFSA Journal. https://doi.org/10.2903/j.efsa.2011.2133
- Burhan I. Ghanayem, Re Bai, Grace E. Kissling et al.. (2009). "Diet-Induced Obesity in Male Mice Is Associated with Reduced Fertility and Potentiation of Acrylamide-Induced Reproductive Toxicity1". Biology of Reproduction. https://doi.org/10.1095/biolreprod.109.078915
- Sean M. Hays, Lesa L. Aylward. (2008). "Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)". Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2008.05.010
- Skott, A., Hofmann, A., Sorgel, F. et al.. (2002). "Acrylamide: Increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans". https://doi.org/10.1159/000069715
- Lawrence, Justin R., O\u27Neill, Feidhlim T., O'Neill, Feidhlim T. et al.. (2001). "Thickness variation of self-processing acrylamide-based photopolymer and reflection holography". https://doi.org/10.1117/1.1353801
- (0). "NIOSH skin notation profile : acrylamide [CAS No. 79-06-1]".
- et al. 2026. "Design and synthesis of carbazole-acrylamide-pyridinium hybrids as dual acetylcholinesterase/butyrylcholinesterase inhibitors and evaluation of their cytotoxic profile on SH-SY5Y and HEK293 cell lines." DOI: 10.1039/d5md01075f. [DOI ↗]
- et al. 2026. "Design, Synthesis, and Cytotoxic Evaluation of <i>N</i>-Phenyl-3-(Thiophen-2-Yl)acrylamide Derivatives." DOI: 10.3390/molecules31183147. [DOI ↗]
- et al. 2026. "Processing-Dependent Acrylamide Formation in French Fries: Optimisation of QuEChERS-Based Extraction and HPLC-PDA Determination." DOI: 10.3390/molecules31162777. [DOI ↗]
- et al. 2026. "Corncob-Derived Xylo-Oligosaccharides Attenuate Acrylamide-Induced Gut-Liver Toxicity in Mice, Associated with Modulation of Gut Microbiota and SCFA Metabolism." DOI: 10.3390/biology15191684. [DOI ↗]
- Kocadağlı, Tolgahan; Gökmen, Vural. 2024. "Metabolism of acrylamide in humans and biomarkers of exposure to acrylamide." Acrylamide in Food. DOI: 10.1016/b978-0-323-99119-3.00010-2. [DOI ↗]
- Kocadağlı, Tolgahan, Gökmen, Vural. 2024. "Metabolism of acrylamide in humans and biomarkers of exposure to acrylamide." Acrylamide in Food: 111-129. https://doi.org/10.1016/b978-0-323-99119-3.00010-2. [DOI ↗]
- 2018. "Acrylamide and Processed Potatoes." Grow: Plant Health Exchange. DOI: 10.1094/grow-pot-11-18-077. [DOI ↗]
- Kocadağlı, Tolgahan; Gökmen, Vural. 2016. "Metabolism of Acrylamide in Humans and Biomarkers of Exposure to Acrylamide." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00006-1. [DOI ↗]
- Anese, Monica. 2016. "Acrylamide in Coffee and Coffee Substitutes." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00009-7. [DOI ↗]
- Mojska, Hanna. 2016. "Secular Trends in Food Acrylamide." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00003-6. [DOI ↗]
- Tepe, Yalçın. 2016. "Acrylamide in Surface and Drinking Water." Acrylamide in Food. DOI: 10.1016/b978-0-12-802832-2.00014-0. [DOI ↗]
- Kocadağlı, Tolgahan, Gökmen, Vural. 2016. "Metabolism of Acrylamide in Humans and Biomarkers of Exposure to Acrylamide." Acrylamide in Food: 109-128. https://doi.org/10.1016/b978-0-12-802832-2.00006-1. [DOI ↗]
- Raloff, Janet. 2002. "Cooking up a carcinogen: Should we worry about all that acrylamide in our diet?." Science News 162 (8): 120-121. https://doi.org/10.2307/4013720. [DOI ↗]
- Anonymous. 1966. "now all the acrylamide you can handle." Chemical & Engineering News Archive 44 (20): 67. https://doi.org/10.1021/cen-v044n020.p067. [DOI ↗]
- "Acrylamide." DOI: 10.31003/uspnf_r8081_02_01. [DOI ↗]
- "Heat-Introduced Formation of Acrylamide in Table Olives: Analysis of Acrylamide, Free Asparagine, and 3Aminopropionamide." DOI: 10.1021/acs.jafc.3c03457.s001. [DOI ↗]
- Anonymous. "Preparation and Cross-Linking of All-Acrylamide Diblock Copolymer Nano-Objects via Polymerization-Induced Self-Assembly in Aqueous Solution.". https://doi.org/10.1021/acs.macromol.6b02643.s001. [DOI ↗]
- et al. 2026. "Design, characterization, DFT studies, and molecular docking of new benzofuran-pyrazol-acrylamide hybrids as insecticidal agents against Spodoptera littoralis and Tribolium castaneum." DOI: 10.1038/s41598-026-39839-z. [DOI ↗]
- et al. 2026. "Acrylamide-Induced Neurotoxicity Is Mitigated by Curcumin and Its Nano Lipid Carrier Formulation in Albino Rats." DOI: 10.1002/tox.70043. [DOI ↗]
- et al. 2026. "ATRA-mediated RAR-α activation attenuates acrylamide-induced testicular toxicity." DOI: 10.1038/s41598-026-50168-z. [DOI ↗]
- et al. 2026. "AC Electrokinetics-Enhanced Capacitive Aptasensor for Point-of-Care Testing of Acrylamide in Coffee." DOI: 10.3390/mi17080966. [DOI ↗]
- 2026. "Acrylamide-Induced Developmental and Molecular Toxicity in Drosophila melanogaster: The Role of Vanillic Acid in CncC/Keap1 Modulation." DOI: 10.1002/jbt.71088. [DOI ↗]
- Bolton, Evan E., Yanli Wang, Paul A. Thiessen, and Stephen H. Bryant. 2008. "PubChem: Integrated Platform of Small Molecules and Biological Activities." Annual Reports in Computational Chemistry 4: 217-241. [DOI ↗]
- Kim, Sunghwan, Jie Chen, Tiejun Cheng, et al. 2023. "PubChem 2023 update." Nucleic Acids Research 51 (D1): D1373-D1380. [DOI ↗]
- Kim, Sunghwan, Tiejun Cheng, Jianyong He, Chen Cheng, et al. 2021. "PubChem Protein, Pathway, Reaction, and Disease Specifications." Journal of Cheminformatics 13: 16. [DOI ↗]
- Hähnke, Volker D., Sunghwan Kim, and Evan E. Bolton. 2018. "PubChem chemical structure standardization." Journal of Cheminformatics 10: 36. [DOI ↗]
- Wang, Yanli, Stephen H. Bryant, Tiejun Cheng, Jiyao Wang, et al. 2017. "PubChem BioAssay: 2017 update." Nucleic Acids Research 45 (D1): D955-D963. [DOI ↗]
- Cheng, Tiejun, et al. 2014. "Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge." Journal of Chemical Information and Modeling 54 (3): 793-805. [DOI ↗]
- 2021. "HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators." DOI: 10.6019/CHEMBL4808148. [ChEMBL bioactivity primary lit] [DOI ↗]
- PubMed PMID PubChem. (Metadata fetch failed.) ↗
- et al. 2026. "Investigation of the effects of acrylamide on tendon healing in rats." DOI: 10.5152/j.aott.2026.25781. [DOI ↗]
- et al. 2026. "Mechanism-guided mitigation of acrylamide in thermally processed foods: emerging technologies and analytical verification." DOI: 10.3389/fnut.2026.1981497. [DOI ↗]
- 2025. "Purification of vegetable oils from acrylamide pollutants using metal-organic frameworks." DOI: 10.1038/s41598-025-28117-z. [DOI ↗]
- Wilkinson, Mark D., et al. 2016. "The FAIR Guiding Principles for scientific data management and stewardship." Scientific Data 3: 160018. [DOI ↗]
- Hersey, Anne, et al. 2015. "Chemical databases: curation or integration by user-defined equivalence?" Drug Discovery Today: Technologies 14: 17-24.
- Mendel Friedman. 2005. "Chemistry and safety of acrylamide in food." Springer. ↗
- United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Environmental Medicine. 2009. "Acrylamide." Agency for Toxic Substances Disease Registry, Division of Toxicology and Environmental Medicine, Dept. of Health and Human Services, Public Health Service. ↗
- Veber, Daniel F., Stephen R. Johnson, Hung-Yuan Cheng, Brian R. Smith, Keith W. Ward, and Kenneth D. Kopple. 2002. "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates." Journal of Medicinal Chemistry 45 (12): 2615-2623.
- Levitt, David. 2024. "Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids." ADMET and DMPK. https://doi.org/10.5599/admet.2414. [DOI ↗]
- Notario, Dion, Munzir, Angela Marietha, Novella, Yulina, Hananta, Linawati. 2024. "Impact of lactoferrin supplementation on cotrimoxazole pharmacokinetics: A preliminary clinical investigation." ADMET and DMPK. https://doi.org/10.5599/admet.2358. [DOI ↗]
- ECHA. 2024. "REACH Guidance." European Chemicals Agency. ↗
- Sridharan, Kannan, Al Banna, Rashed, Husain, Aysha. 2021. "Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model." ADMET and DMPK. https://doi.org/10.5599/admet.909. [DOI ↗]
- Cabana, Bernard E.. 1984. "Bioavailability and Pharmacokinetics in Drug Development." Pharmacokinetics: 113-132. https://doi.org/10.1007/978-1-4613-2799-8_12. [DOI ↗]
- Groom, Colin R., Ian J. Bruno, Matthew P. Lightfoot, and Suzanna C. Ward. 2016. "The Cambridge Structural Database." Acta Crystallographica Section B 72 (2): 171-179. ↗
🧪 Solution preparation assistant (Smart Prep) MolGod_PREP_2
Enter what you want to prepare — I'll generate an SOP
📚 Scientific literature overview — CAS 79-06-1MolGod_LITHUB_MAIN
⭐ Key findings (scientific literature) 20 publications
79-06-1
— multi-criteria ranking (W12): 30% citations · 20% recency · 20% topic · 15% historical · 15% open access.
-
#1et al. (2026) · Scientific ReportsWhy it matters: Recent (2026) · open access
-
#2et al. (2026) · Frontiers in NutritionWhy it matters: Recent (2026) · open access
-
#3et al. (2026) · MoleculesWhy it matters: Recent (2026) · open access
-
#4Reda M. Abdelhameed; Randa S. Hasan; Hassan Abdel-Gawad (2025) · Scientific ReportsWhy it matters: Recent (2025) · open access
-
#5et al. (2026) · BiologyWhy it matters: Recent (2026) · open access
-
#6AC Electrokinetics-Enhanced Capacitive Aptasensor for Point-of-Care Testing of Acrylamide in Coffee.et al. (2026) · MicromachinesWhy it matters: Recent (2026) · open access
-
#7et al. (2026) · Environmental ToxicologyWhy it matters: Recent (2026) · open access
-
#8et al. (2026) · MoleculesWhy it matters: Recent (2026) · open access
-
#9et al. (2026) · RSC Medicinal ChemistryWhy it matters: Recent (2026) · open access
-
#10et al. (2026) · Acta Orthopaedica et Traumatologica TurcicaWhy it matters: Recent (2026) · open access
-
#11et al. (2026) · Scientific ReportsWhy it matters: Recent (2026) · open access
-
#12Fahriye Zemheri‐Navruz; Sinan Ince; Gamze Ataman (2026) · Journal of Biochemical and Molecular ToxicologyWhy it matters: Recent (2026) · open access
-
#13et al. (2026) · GelsWhy it matters: Recent (2026) · open access
-
#14Eman M.S. Shaheen; Marwa A. E. Abd El‐Maksoud (2026) · Journal of Biochemical and Molecular ToxicologyWhy it matters: Recent (2026) · open access
-
#15Milan Mandal; Seth Agrippa Oppong; Keka Ojha (2026) · ACS OmegaWhy it matters: Recent (2026) · open access
-
#16J. Wojciechowska-Puchałka, E. Drąg-Kozak, K. Kustra et al. (2026) · Poultry ScienceWhy it matters: Recent (2026) · open access
-
#17Ghanayem BI; Bai R; Kissling GE et al. (2010) · Biology of reproductionWhy it matters: Must-cite (canon) · 131 citations
-
#18et al. (2026) · BMC Pharmacology and ToxicologyWhy it matters: Recent (2026) · open access
-
#19Seyed Jamaleddin Peighambardoust, Hamzeh Khatooni, Naeimeh Sadat Peighambardoust (2026) · Scientific ReportsWhy it matters: Recent (2026) · open access
-
#20Damian Chandia-Poblete, Stéphane Tuffier, Efstathios Vryonidis et al. (2026) · EClinicalMedicineWhy it matters: Recent (2026) · open access
📚 REFERENCES (Aggregate bibliography, Chicago Author-Date) 107 items
All scientific sources cited in the accordions above for CAS 79-06-1. Format: Chicago Manual of Style 17th ed., Author-Date system.
🗄️ Scientific databases
- NIST. 2026. NIST Chemistry WebBook: CAS 79-06-1. Gaithersburg, MD: National Institute of Standards and Technology. https://webbook.nist.gov/cgi/cbook.cgi?ID=79-06-1. (Accessed 2026-11-12.)
- AIST. 2026. Spectral Database for Organic Compounds (SDBS): CAS 79-06-1. Tsukuba, Japan: National Institute of Advanced Industrial Science and Technology. https://sdbs.db.aist.go.jp/. (Accessed 2026-11-12.)
- PubChem. 2026. PubChem Compound Summary: CAS 79-06-1. Bethesda, MD: National Center for Biotechnology Information (NCBI), National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/#query=79-06-1. (Accessed 2026-11-12.)
- ECHA. 2026. C&L Inventory and REACH Registration: CAS 79-06-1. Helsinki: European Chemicals Agency. https://echa.europa.eu/information-on-chemicals/annex-vi-to-clp. (Accessed 2026-11-12.)
📐 Standards / Guidelines
- ICH. 2026. "ICH Harmonised Guideline: CAS 79-06-1." Geneva: International Council for Harmonisation. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf. (Accessed 2026-11-12.)
- National Fire Protection Association (NFPA). 2024. "NFPA 30: Flammable and Combustible Liquids Code." NFPA, Quincy, MA. https://www.nfpa.org/codes-and-standards/all-codes-and-standards/list-of-codes-and-standards/detail?code=30.
- Occupational Safety and Health Administration (OSHA). 2023. "29 CFR 1910.106 — Flammable Liquids." U.S. Department of Labor, Federal Register. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.106.
- European Chemicals Agency (ECHA). 2024. "Annex VI to Regulation (EC) No 1272/2008 (CLP) — Harmonised Classification and Labelling." ECHA, Helsinki / Official Journal of the European Union. https://echa.europa.eu/regulations/clp/clp-classification.
- European Committee for Standardization (CEN). 2016. "EN 374-1:2016 — Protective gloves against dangerous chemicals and micro-organisms — Part 1: Terminology and performance requirements for chemical risks." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=205:110:::::FSP_PROJECT,FSP_ORG_ID:38536,6080&cs=1B0DAA8B85DF42E4A2C70E5D71F0BFA32.
- European Committee for Standardization (CEN). 2001. "EN 166:2001 — Personal eye-protection — Specifications." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:6541&cs=1F1A4E0A78C4DB6A28DBE2E8C29D89DCF.
- European Committee for Standardization (CEN). 2009. "EN 14605:2005+A1:2009 — Protective clothing against liquid chemicals — Performance requirements for clothing with liquid-tight (Type 3) or spray-tight (Type 4) connections." CEN, Brussels. https://standards.cencenelec.eu/dyn/www/f?p=CEN:110:0::::FSP_PROJECT:21581&cs=1A04A2D3C7CC58E9E6CB58D55F7EBFB7E.
- National Institute for Occupational Safety and Health (NIOSH). 2017. "Recommendations for Chemical Protective Clothing: A Companion to the NIOSH Pocket Guide." U.S. Department of Health & Human Services / CDC. https://www.cdc.gov/niosh/ncpc/default.html.
- Occupational Safety and Health Administration (OSHA). 2011. "Personal Protective Equipment — General requirements." U.S. Department of Labor — 29 CFR 1910.132. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.132.
📖 Books
- Hansen, Charles M. 2007. Hansen Solubility Parameters: A User's Handbook, 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/Hansen-Solubility-Parameters-A-Users-Handbook/Hansen/p/book/9780849372483.
- Barton, Allan F. M. 1991. CRC Handbook of Solubility Parameters and Other Cohesion Parameters: 2nd ed.. Boca Raton, FL: CRC Press. https://www.routledge.com/CRC-Handbook-of-Solubility-Parameters-and-Other-Cohesion-Parameters/Barton/p/book/9780849301766.
- Connors, Kenneth A., Gordon L. Amidon, and Valentino J. Stella. 1986. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd ed.. New York: Wiley. https://doi.org/10.1002/0471734683.
- Rumble, John R., ed. 2019. CRC Handbook of Chemistry and Physics: 100th Edition. Boca Raton, FL: CRC Press. https://hbcp.chemnetbase.com/.
- Urben, Peter G. 2017. Bretherick's Handbook of Reactive Chemical Hazards, 8th Edition. Academic Press / Elsevier, Oxford. https://www.sciencedirect.com/book/9780081010594.
📘 Monographs
- IARC. 2026. IARC Monographs on the Identification of Carcinogenic Hazards to Humans: CAS 79-06-1. Lyon, France: International Agency for Research on Cancer, World Health Organization. https://monographs.iarc.who.int/list-of-classifications/. (Accessed 2026-11-12.)
📄 Scientific articles (peer-reviewed)
- Stefanis, Emmanuel, and Costas Panayiotou. 2008. "Prediction of Hansen Solubility Parameters with a New Group-Contribution Method." International Journal of Thermophysics 29: 568-585. https://doi.org/10.1007/s10765-008-0415-z.
- Stoll, Vincent S., and John S. Blanchard. 1990. "Buffers: Principles and Practice: In Methods in Enzymology, vol. 182." San Diego: Academic Press. https://doi.org/10.1016/0076-6879(90)82008-P.
🌐 Websites
- ECHA. 2023. "Guidance on the Application of the CLP Criteria." European Chemicals Agency. https://echa.europa.eu/guidance-documents/guidance-on-clp.
- European Parliament. 2006. "Regulation (EC) No 1907/2006 (REACH)." Official Journal of the European Union L 396: 1–849.
- ECHA. 2023. "Candidate List of Substances of Very High Concern for Authorisation." European Chemicals Agency. https://echa.europa.eu/candidate-list-table.
- European Parliament. 2008. "Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures (CLP)." Official Journal of the European Union L 353: 1–1355.
- ECHA. 2017. "Guidance on the Compilation of Safety Data Sheets." Version 3.1. European Chemicals Agency. ECHA-17-G-01-EN. https://echa.europa.eu/documents/10162/23047722/sds_en.pdf.
- ECHA. 2022. "Restrictions Under REACH — Annex XVII." European Chemicals Agency. https://echa.europa.eu/substances-restricted-under-reach.
- United Nations. 2021. Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 9th revised ed. ST/SG/AC.10/30/Rev.9. New York and Geneva: United Nations. https://unece.org/ghs-rev9-2021.
- ECHA. 2020. "Understanding REACH." European Chemicals Agency. https://echa.europa.eu/regulations/reach/understanding-reach.
- U.S. OSHA. 2026. "Occupational Safety and Health Guidance: CAS 79-06-1." Washington, DC: U.S. Occupational Safety and Health Administration. https://www.osha.gov/hazwoper. (Accessed 2026-11-12.)
- National Fire Protection Association (2018) — NFPA 472: Standard for Competence of Responders to Hazardous Materials/Weapons of Mass Destruction Incidents https://www.nfpa.org/codes-and-standards/nfpa-472.
- European Union. 2026. "EUR-Lex Legal Database: CAS 79-06-1." Luxembourg: Publications Office of the European Union. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32012L0018. (Accessed 2026-11-12.)
- U.S. National Institute for Occupational Safety and Health (2024) — NIOSH Pocket Guide to Chemical Hazards https://www.cdc.gov/niosh/npg/.
- Snyder, Lloyd R., John W. Dolan, and Joseph J. Kirkland. 2010. Introduction to Modern Liquid Chromatography. Wiley.
- Schoenmakers, Peter J.. 1986. Optimization of Chromatographic Selectivity: A Guide to Method Development. Elsevier.
- Snyder, L. R., and J. W. Dolan. 2007. High-Performance Gradient Elution: The Practical Application of the Linear-Solvent-Strength Model. Wiley.
- Nikitas, Pavlos, and Adrian Pappa-Louisi. 2009. "Retention models for isocratic and gradient elution in reversed-phase liquid chromatography." Journal of Chromatography A 1216: 1737-1755. https://doi.org/10.1016/j.chroma.2008.10.005.
- Carr, Peter W.. 2009. "The new physical chemistry of HPLC." Journal of Chromatography A 1216: 1764-1772. https://doi.org/10.1016/j.chroma.2008.11.094.
- Dong, Michael W.. 2019. HPLC and UHPLC for Practicing Scientists. Wiley. https://doi.org/10.1002/9781119313793.
- Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." Journal of Separation Science 30: 1167-1182. https://doi.org/10.1002/jssc.200700026.
- Dolan, John W.. 2013. "When to Modify Method Conditions." LCGC North America 31: 192-199. https://www.chromatographyonline.com/view/when-modify-method-conditions.
- Meyer, Veronika R.. 2010. Practical High-Performance Liquid Chromatography. Wiley.
- Engelhardt, Heinz. 2014. 100 Years of Chromatography. Wiley-VCH.
- Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." Analytical Chemistry 82: 8525-8531. https://doi.org/10.1021/ac101742z.
- Van Deemter, J. J., F. J. Zuiderweg, and A. Klinkenberg. 1956. "Longitudinal diffusion and resistance to mass transfer as causes of nonideality in chromatography." https://doi.org/10.1016/0009-2509(56)80003-1.
- Giddings, J. Calvin. 1965. "Dynamics of Chromatography, Part I: Principles and Theory." Marcel Dekker.
- Poppe, Hans. 1997. "Some reflections on speed and efficiency of modern chromatographic methods." https://doi.org/10.1016/S0021-9673(97)00376-2.
- Wu, Naijun, and Anton M. Clausen. 2007. "Fundamental and practical aspects of ultrahigh pressure liquid chromatography for fast separations." https://doi.org/10.1002/jssc.200700026.
- Carr, Peter W.. 2009. "The new physical chemistry of HPLC." https://doi.org/10.1016/j.chroma.2008.11.094.
- Knox, John H.. 1977. "Practical aspects of LC theory." https://doi.org/10.1093/chromsci/15.9.352.
- Snyder, L. R., J. J. Kirkland, and J. L. Glajch. 1997. "Practical HPLC Method Development." Wiley.
- Vivó-Truyols, Gabriel, and Hans-Gerd Janssen. 2010. "Probabilistic approach to peak deconvolution in chromatography." https://doi.org/10.1021/ac101742z.
- Sadek, Paul C.. 2002. "The HPLC Solvent Guide." Wiley-Interscience.
- Snyder, L. R.. 1978. "Classification of the solvent properties of common liquids." https://doi.org/10.1093/chromsci/16.6.223.
- Reichardt, Christian, and Thomas Welton. 2010. "Solvents and Solvent Effects in Organic Chemistry." Wiley-VCH.
- Vailaya, Anant, and Csaba Horváth. 1998. "Retention thermodynamics in hydrophobic interaction chromatography." https://doi.org/10.1021/ie980212h.
- Krstulović, Andrea M., and Phyllis R. Brown. 1981. "Reversed-phase High-Performance Liquid Chromatography." Wiley.
- Boysen, Reinhard I., and Milton T. W. Hearn. 2009. "Multi-modal HPLC of proteins." https://doi.org/10.1093/chromsci/47.8.645.
- USP General Chapter <621>. 2024. "Chromatography." United States Pharmacopeial Convention. https://www.usp.org/harmonization-standards/pdg/general-chapters/chromatography.
- Foley, Joe P., and John G. Dorsey. 1983. "Equations for calculation of chromatographic figures of merit for ideal and skewed peaks." https://doi.org/10.1021/ac00255a033.
- Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." Wiley. https://doi.org/10.1002/9780470508183.
- Dolan, John W.. 2003. "Peak tailing and resolution." https://www.chromatographyonline.com/view/peak-tailing-and-resolution.
- Kromidas, Stavros. 2017. "HPLC Made to Measure: A Practical Handbook for Optimization." Wiley-VCH.
- Heyden, Yvan Vander, et al.. 2009. "Robustness of pharmaceutical liquid chromatographic methods." https://doi.org/10.1016/j.jchromb.2008.10.052.
- United States Pharmacopeial Convention. 2024. "USP <621> Chromatography." In United States Pharmacopeia and National Formulary, USP 47-NF 42. Rockville, MD: USP. https://www.uspnf.com/.
- European Pharmacopoeia Commission. 2024. "2.2.46 Chromatographic Separation Techniques." In European Pharmacopoeia, 11th ed. Strasbourg: Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
- International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories." Geneva: ISO. https://www.iso.org/standard/66912.html.
- Kolthoff, Izaak Maurits, and Philip J. Elving, eds. 1978. Treatise on Analytical Chemistry, Part I: Theory and Practice. 2nd ed. New York: Wiley-Interscience.
- Skoog, Douglas A., F. James Holler, and Stanley R. Crouch. 2018. Principles of Instrumental Analysis. 7th ed. Boston: Cengage Learning.
- Christian, Gary D., Purnendu K. Dasgupta, and Kevin A. Schug. 2014. Analytical Chemistry. 7th ed. Hoboken, NJ: Wiley.
- EURACHEM/CITAC. 2012. "Quantifying Uncertainty in Analytical Measurement." 3rd ed. EURACHEM/CITAC Guide CG 4. https://www.eurachem.org/images/stories/Guides/pdf/QUAM2012_P1.pdf.
- Snyder, Lloyd R., Joseph J. Kirkland, and John W. Dolan. 2010. "Introduction to Modern Liquid Chromatography." John Wiley & Sons. https://doi.org/10.1002/9780470508183.
- Dolan, John W.. 2003. "How much resolution is enough?." https://www.chromatographyonline.com/view/how-much-resolution-enough.
- USP General Chapter <621>. 2024. "Chromatography (System Suitability section)." United States Pharmacopeial Convention. https://www.usp.org/harmonization-standards/pdg/general-chapters/chromatography.
- U.S. FDA. 2026. "FDA Guidance and Resources: CAS 79-06-1." Silver Spring, MD: U.S. Food and Drug Administration. https://www.fda.gov/media/74954/download. (Accessed 2026-11-12.)
- Rozet, Eric, et al.. 2013. "Analysis of recent pharmaceutical regulatory documents on analytical method validation." https://doi.org/10.1016/j.chroma.2007.03.111.
- European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf.
- Kazakevich, Yuri V., and Rosario LoBrutto, eds.. 2007. "HPLC for Pharmaceutical Scientists." Wiley-Interscience. https://doi.org/10.1002/9780470087954.
- AOAC International. 2016. "Appendix F: Guidelines for Standard Method Performance Requirements." AOAC INTERNATIONAL. https://www.aoac.org/wp-content/uploads/2019/08/app_f.pdf.
- International Organization for Standardization. 1994. "ISO 5725-2:1994 Accuracy (Trueness and Precision) of Measurement Methods and Results — Part 2: Basic Method for the Determination of Repeatability and Reproducibility of a Standard Measurement Method." Geneva: ISO. https://www.iso.org/standard/11834.html.
- Grubbs, Frank E. 1950. "Sample Criteria for Testing Outlying Observations." Annals of Mathematical Statistics 21 (1): 27–58.
- Dixon, Wilfrid J. 1950. "Analysis of Extreme Values." Annals of Mathematical Statistics 21 (4): 488–506.
- Snedecor, George W., and William G. Cochran. 1989. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press.
- Student [William Sealy Gosset]. 1908. "The Probable Error of a Mean." Biometrika 6 (1): 1–25.
- International Organization for Standardization. 2005. "ISO 3534-1:2006 Statistics — Vocabulary and Symbols — Part 1: General Statistical Terms and Terms Used in Probability." Geneva: ISO. https://www.iso.org/standard/40145.html.
- Thompson, Michael, Stephen L. R. Ellison, and Roger Wood. 2002. "Harmonized Guidelines for Single-Laboratory Validation of Methods of Analysis." Pure and Applied Chemistry 74 (5): 835–855.
- United Nations Economic Commission for Europe. 2024. European Agreement Concerning the International Carriage of Dangerous Goods by Road (ADR), Applicable as from 1 January 2025 (ECE/TRANS/352). Geneva: UNECE. https://unece.org/transport/dangerous-goods/adr-2025-edition.
- International Air Transport Association. 2026. Dangerous Goods Regulations (DGR). 67th ed. Montreal: IATA. https://www.iata.org/en/programs/cargo/dgr/.
- International Maritime Organization. 2024. International Maritime Dangerous Goods (IMDG) Code, 2024 Edition (Amendment 42-24). London: IMO. https://www.imo.org/en/OurWork/Safety/Pages/DangerousGoods-default.aspx.
- United Nations. 2025. Recommendations on the Transport of Dangerous Goods: Model Regulations (Orange Book). 24th revised ed. ST/SG/AC.10/1/Rev.24. New York and Geneva: United Nations. https://unece.org/transport/dangerous-goods/un-model-regulations.
- International Civil Aviation Organization. 2025. Technical Instructions for the Safe Transport of Dangerous Goods by Air (Doc 9284). 2025–2026 ed. Montreal: ICAO. https://www.icao.int/safety/DangerousGoods/Pages/technical-instructions.aspx.
- United States Pharmacopeia (USP) Convention. 2024. "USP General Chapter <621> Chromatography." USP. https://www.usp.org/sites/default/files/usp/document/harmonization/gen-chapter/g05_pf_30_4_2004.pdf.
- European Medicines Agency (EMA). 2011. "Guideline on bioanalytical method validation EMEA/CHMP/EWP/192217/2009." EMA Committee for Medicinal Products for Human Use. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf.
- Sejm RP. 2026. "Internetowy System Aktow Prawnych (ISAP): CAS 79-06-1." Warszawa: Kancelaria Sejmu Rzeczypospolitej Polskiej. https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20200000010. (Accessed 2026-11-12.)
- Ministerstwo Klimatu i Srodowiska. 2026. "Baza Danych o Odpadach (BDO): CAS 79-06-1." Warszawa: Ministerstwo Klimatu i Srodowiska. https://bdo.mos.gov.pl/. (Accessed 2026-11-12.)
- Pohanish, Richard P.. 2017. "Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens." Elsevier.
- Lewis, Richard J.. 2012. "Sax's Dangerous Properties of Industrial Materials." Wiley.
- NIOSH. 2024. "Pocket Guide to Chemical Hazards." U.S. Department of Health and Human Services. https://www.cdc.gov/niosh/npg/.
- United Nations Economic Commission for Europe (UNECE). 2023. "European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR 2025)." UNECE. https://unece.org/transport/standards/transport/dangerous-goods/adr-2025.
- IPCS INCHEM. 2024. "International Programme on Chemical Safety — Waste Management Guidelines." WHO/UNEP/ILO. https://www.inchem.org/.
- International Organization for Standardization. 2017. "ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories." ISO. https://www.iso.org/standard/66912.html.
- World Health Organization. 2010. "WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles (WHO Technical Report Series No. 957, Annex 3)." WHO Press. https://www.who.int/publications/m/item/trs957-annex3.
- European Medicines Agency. 2014. "Guideline on Process Validation for Finished Products — Information and Data to Be Provided EMA/CHMP/CVMP/QWP/BWP/70278/2012." European Medicines Agency. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions-revision-1_en.pdf.
- United States Pharmacopeial Convention. 2024. "United States Pharmacopeia and National Formulary, USP 47-NF 42." USP. https://www.uspnf.com/.
- European Pharmacopoeia Commission. 2024. "European Pharmacopoeia 11th Edition." Council of Europe — EDQM. https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-11th-edition.
- Pharmaceutical Inspection Co-operation Scheme (PIC/S). 2021. "Guide to Good Manufacturing Practice for Medicinal Products PE 009-15." PIC/S Secretariat, Geneva. https://picscheme.org/en/publications.
- International Pharmaceutical Excipients Council (IPEC) and Pharmaceutical Quality Group (PQG). 2017. "Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients." IPEC-Americas. https://ipecamericas.org/sites/default/files/IPECPQGGMPGuide2017.pdf.




